Menu
Your Cart

Recombinant Proteins

Molgenics Life Sciences has laboratory-manufactured, purified proteins which can be used in medicine, research and biotechnology. We have an expansive portfolio of recombinant proteins for applications such as cell growth, cell signalling, chemical production and cosmetic use. Our website provides a wide array of recombinant proteins for research purposes.

PLA2R is a type I transmembrane glycoprotein of 180–200 kDa and is present in a wide variety of cells and tissues (1). Receptor for secretory phospholipase A2 (sPLA2) belonging to the mannose receptor family (2). It is composed of a large extracellular N-terminal portion, consisting of a N-ter..
£340.00
Cell adhesion protein that participates in lymphocyte extravasation and recirculation by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells in an L-selectin-independent fashion (1, 2). Has semicarbazide-sensitive (SSAO) monoamine oxidase activity (3, 4). May pla..
£160.00
THSD7A was first identified as an endothelial protein that is expressed in the vascular system of the placenta (1). It is expressed by cells of endothelial and neuronal lineage. The soluble form of THSD7A promotes endothelial cell migration and filopodia forma..
£300.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β - CoV  (1), named SARS CoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike pr..
£490.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β-CoV (1), named SARSCoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike protein at..
£490.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β-CoV (1), named SARS-CoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike protein ..
£490.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β-CoV (1), named SARS-CoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike protein ..
£490.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β-CoV (1), named SARS-CoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike protein ..
£490.00
The first reports of atypical pneumonia in China were announced at the very end of 2019, in the city of Wuhan, Hubei province. Its cause was identified in January 2020 as a novel β-CoV (1), named SARS-CoV-2, which started spreading very quickly causing a global pandemic COVID-19. Spike protein ..
£490.00
Showing 13 to 21 of 21 (2 Pages)